Fulcrum Therapeutics Inc. (FULC) Tops Q1 EPS by 5c

Fulcrum Therapeutics Inc. (NASDAQ: FULC) reported Q1 EPS of ($0.25), $0.05 better than the analyst estimate of ($0.30).

For earnings history and earnings-related data on Fulcrum Therapeutics Inc. (FULC) click here.

You May Also Be Interested In

• S&P shares jump report of potential CapIQ spinout
• Popular stocks with increasing option volume: MU SPCX INTC ORCL PFE PLTR SOFI PBR MSTR HOOD SNDK MRVL
• Energy Vault’s 100 MW AI Infrastructure Project in Sardinia Receives Italian Government Designation as Project of Pre-Eminent National Strategic Interest